249 related articles for article (PubMed ID: 31445840)
21. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
Lee DK; Song SU
Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
[TBL] [Abstract][Full Text] [Related]
23. Role of mesenchymal stem cells and short chain fatty acids in allergy: A prophylactic therapy for future.
Mohanan MM; Shetty R; Bang-Berthelsen CH; Mudnakudu-Nagaraju KK
Immunol Lett; 2023 Aug; 260():1-10. PubMed ID: 37271295
[TBL] [Abstract][Full Text] [Related]
24. Identifying the Therapeutic Significance of Mesenchymal Stem Cells.
Mishra VK; Shih HH; Parveen F; Lenzen D; Ito E; Chan TF; Ke LY
Cells; 2020 May; 9(5):. PubMed ID: 32384763
[TBL] [Abstract][Full Text] [Related]
25. Serum from Asthmatic Mice Potentiates the Therapeutic Effects of Mesenchymal Stromal Cells in Experimental Allergic Asthma.
Abreu SC; Xisto DG; de Oliveira TB; Blanco NG; de Castro LL; Kitoko JZ; Olsen PC; Lopes-Pacheco M; Morales MM; Weiss DJ; Rocco PRM
Stem Cells Transl Med; 2019 Mar; 8(3):301-312. PubMed ID: 30426724
[TBL] [Abstract][Full Text] [Related]
26. MSCs: Biological characteristics, clinical applications and their outstanding concerns.
Si YL; Zhao YL; Hao HJ; Fu XB; Han WD
Ageing Res Rev; 2011 Jan; 10(1):93-103. PubMed ID: 20727988
[TBL] [Abstract][Full Text] [Related]
27. The genes involved in asthma with the treatment of human embryonic stem cell-derived mesenchymal stem cells.
Lin YD; Fan XL; Zhang H; Fang SB; Li CL; Deng MX; Qin ZL; Peng YQ; Zhang HY; Fu QL
Mol Immunol; 2018 Mar; 95():47-55. PubMed ID: 29407576
[TBL] [Abstract][Full Text] [Related]
28. The Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Treatment of Neurodegenerative Diseases.
Gorabi AM; Kiaie N; Barreto GE; Read MI; Tafti HA; Sahebkar A
Mol Neurobiol; 2019 Dec; 56(12):8157-8167. PubMed ID: 31197655
[TBL] [Abstract][Full Text] [Related]
29. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells.
Liu J; Liu Q; Chen X
Front Immunol; 2020; 11():1843. PubMed ID: 32922398
[TBL] [Abstract][Full Text] [Related]
30. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
32. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.
Fan XL; Zeng QX; Li X; Li CL; Xu ZB; Deng XQ; Shi J; Chen D; Zheng SG; Fu QL
Stem Cell Res Ther; 2018 Jun; 9(1):170. PubMed ID: 29921316
[TBL] [Abstract][Full Text] [Related]
33. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
[TBL] [Abstract][Full Text] [Related]
34. Eicosapentaenoic Acid Enhances the Effects of Mesenchymal Stromal Cell Therapy in Experimental Allergic Asthma.
Abreu SC; Lopes-Pacheco M; da Silva AL; Xisto DG; de Oliveira TB; Kitoko JZ; de Castro LL; Amorim NR; Martins V; Silva LHA; Gonçalves-de-Albuquerque CF; de Castro Faria-Neto HC; Olsen PC; Weiss DJ; Morales MM; Diaz BL; Rocco PRM
Front Immunol; 2018; 9():1147. PubMed ID: 29881388
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
36. Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses.
Yang C; Li J; Lin H; Zhao K; Zheng C
PLoS One; 2015; 10(3):e0118849. PubMed ID: 25739057
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
Ben-Ami E; Berrih-Aknin S; Miller A
Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813471
[TBL] [Abstract][Full Text] [Related]
40. In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model.
Oh EJ; Lee HW; Kalimuthu S; Kim TJ; Kim HM; Baek SH; Zhu L; Oh JM; Son SH; Chung HY; Ahn BC
J Control Release; 2018 Jun; 279():79-88. PubMed ID: 29655989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
